Literature DB >> 21976044

Cognitive mechanisms of treatment in depression.

Jonathan P Roiser1, Rebecca Elliott, Barbara J Sahakian.   

Abstract

Cognitive abnormalities are a core feature of depression, and biases toward negatively toned emotional information are common, but are they a cause or a consequence of depressive symptoms? Here, we propose a 'cognitive neuropsychological' model of depression, suggesting that negative information processing biases have a central causal role in the development of symptoms of depression, and that treatments exert their beneficial effects by abolishing these biases. We review the evidence pertaining to this model: briefly with respect to currently depressed patients, and in more detail with respect to individuals at risk for depression and the effects of antidepressant treatments. As well as being present in currently depressed individuals, negative biases are detectable in those vulnerable for depression due to neuroticism, genetic risk, or previous depressive illness. Recent evidence provides strong support for the notion that both antidepressant drugs and psychological therapies modify negative biases, providing a common mechanism for understanding treatments for depression. Intriguingly, it may even be possible to predict which patients will benefit most from which treatments on the basis of neural responses to negative stimuli. However, further research is required to ascertain whether negative processing biases will be useful in predicting, detecting, and treating depression, and hence in preventing a chronic, relapsing course of illness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976044      PMCID: PMC3238070          DOI: 10.1038/npp.2011.183

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  259 in total

1.  Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression.

Authors:  Frederik M van der Veen; Elisabeth A T Evers; Nicolaas E P Deutz; Jeroen A J Schmitt
Journal:  Neuropsychopharmacology       Date:  2006-10-04       Impact factor: 7.853

2.  A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

Authors:  Maurizio Fava; Michael E Thase; Charles DeBattista
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

3.  Amygdala reactivity and mood-congruent memory in individuals at risk for depressive relapse.

Authors:  Wiveka Ramel; Philippe R Goldin; Lisa T Eyler; Gregory G Brown; Ian H Gotlib; John R McQuaid
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

4.  Social functioning and personality of subjects at familial risk for affective disorder.

Authors:  Heidemarie Hecht; Stephanie Genzwürker; Mark Helle; Dietrich van Calker
Journal:  J Affect Disord       Date:  2005-01       Impact factor: 4.839

Review 5.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

6.  Neural substrates of increased memory sensitivity for negative stimuli in major depression.

Authors:  J Paul Hamilton; Ian H Gotlib
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

7.  Personality traits in children of parents with unipolar and bipolar mood disorders.

Authors:  Stephane Rothen; Caroline Louise Vandeleur; Yodok Lustenberger; Nicolas Jeanprêtre; Eve Ayer; Daniel Fornerod; Franziska Gamma; Tania Teichmann; Olivier Halfon; François Ferrero; Martin Preisig
Journal:  J Affect Disord       Date:  2008-06-27       Impact factor: 4.839

8.  A prospective trial of modafinil as an adjunctive treatment of major depression.

Authors:  Charles DeBattista; Anna Lembke; H Brent Solvason; Rahwa Ghebremichael; Jennifer Poirier
Journal:  J Clin Psychopharmacol       Date:  2004-02       Impact factor: 3.153

9.  A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder.

Authors:  Simon Surguladze; Michael J Brammer; Paul Keedwell; Vincent Giampietro; Andrew W Young; Michael J Travis; Steven C R Williams; Mary L Phillips
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

10.  Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study.

Authors:  Ian M Anderson; Cristina M Del-Ben; Shane Mckie; Paul Richardson; Stephen R Williams; Rebecca Elliott; J F William Deakin
Journal:  Neuroreport       Date:  2007-08-27       Impact factor: 1.837

View more
  136 in total

1.  Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat.

Authors:  Collin Challis; Janette Boulden; Avin Veerakumar; Julie Espallergues; Fair M Vassoler; R Christopher Pierce; Sheryl G Beck; Olivier Berton
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

2.  Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.

Authors:  Boadie W Dunlop; Steven P Cole; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  J Affect Disord       Date:  2017-12-27       Impact factor: 4.839

3.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

4.  Innovative methods for improving cognition, motivation and wellbeing in schizophrenia.

Authors:  Barbara J Sahakian; George Savulich
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

5.  Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial.

Authors:  Camilla L Nord; D Chamith Halahakoon; Tarun Limbachya; Caroline Charpentier; Níall Lally; Vincent Walsh; Judy Leibowitz; Stephen Pilling; Jonathan P Roiser
Journal:  Neuropsychopharmacology       Date:  2019-04-30       Impact factor: 7.853

6.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

7.  Depression severity is associated with impaired facial emotion processing in a large international sample.

Authors:  Lauren A Rutter; Eliza Passell; Luke Scheuer; Laura Germine
Journal:  J Affect Disord       Date:  2020-07-10       Impact factor: 4.839

8.  Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression.

Authors:  Matthew R Hilimire; Helen S Mayberg; Paul E Holtzheimer; James M Broadway; Nathan A Parks; Jordan E DeVylder; Paul M Corballis
Journal:  Brain Stimul       Date:  2014-11-24       Impact factor: 8.955

9.  Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.

Authors:  Agnes Norbury; Sarah B Rutter; Abigail B Collins; Sara Costi; Manish K Jha; Sarah R Horn; Marin Kautz; Morgan Corniquel; Katherine A Collins; Andrew M Glasgow; Jess Brallier; Lisa M Shin; Dennis S Charney; James W Murrough; Adriana Feder
Journal:  Neuropsychopharmacology       Date:  2021-07-31       Impact factor: 7.853

Review 10.  Future directions in vulnerability to depression among youth: integrating risk factors and processes across multiple levels of analysis.

Authors:  Benjamin L Hankin
Journal:  J Clin Child Adolesc Psychol       Date:  2012-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.